for 2 weeks of the 3 before the TH was announced, ADO was trading bw 3.8 - 4c
got sold down to 3.5c in the week beforehand. ado finished this week at 2.4c so a 3o% drop ( or a 40% drop from the weeks beforehand)
non participating s/holders have been diluted but plenty has happened since the TH ann apart from the $6.2m extra we have in the bank
23/4
"In January 2024, management met with senior representatives from the Serum Institute of India (SII) at their headquarters in India. SII are the world’s leading vaccine manufacturer and are currently using AnteoBindTM in the development of a new vaccine. The incorporation of AnteoBind into a vaccine manufacturing process, if approved by international regulatory bodies, would ensure AnteoBind would be used for the life of the vaccine which is typically more than 20-years, providing a long-term annuity-style revenue stream for AnteoTech. The discussions for an initial commercial contract are well advanced."
1/5
"AnteoTech also advises the first production-scale batch of Anteo X has commenced in its facility at Eight Mile Plains. The initial batches will be used for external validations that are currently underway as well as internal development work."
22/5
"As a result of this successful validation, EV1 have advised they will now incorporate Anteo XTM into the prototyping process for their next generation batteries, to further validate Anteo XTM in the next stage of the battery development process."
"Follow-up face to face meetings are planned for mid-June prior to The Battery Show in Stuttgart that, if successful, will see the development of a program to incorporate AnteoTech’s proprietary silicon anode technology into this process and enable EV2 to complete this objective."
"The sales funnel of opportunities for AnteoTech has been further developed as a result of meetings with three additional electric vehicle manufacturers from Europe."
"As advised, validation work is underway with several leading global battery manufacturers with this process expected to be completed within 6 months of commencement. Further opportunities have arisen as a result of the Company presentation at AABC and include batteries for vertical take-off equipment, starter batteries for EVs and a range of e-mobility products."
"AnteoTech plans to provide greater support for existing and new potential customers in Europe, by establishing a sales office and presence in Europe. A key element of this strategy is recruitment of a European based International Sales Director with a deep sales background and strong commercial track record to be a member of the Leadership Team. Initial meetings were held with several senior candidates from within the battery industry, with further interviews planned prior to The Battery Show in June."
to sum up
- the company has an extra $6.2m
-management travelled to india to progress vaccine development with SIOI
-with ev1, AnteoX enhanced anode reached 1000 cycles
-1st first production-scale batch of AnteoX run
-anteo X to be included in ev1's prototype, meeting in next 2-3 weeks
-ev2 progressed and dealing with 3 more ev companies
-3 battery manufacturers running testing, thought to take 6 mths, cs1 have had a MTA for close on 3mths
-added 3 more testers "vertical take-off equipment, starter batteries for EVs and a range of e-mobility products."
-plans underway for European sales office with int sales director interviews in the next 3 weeks.
as I said the market is a funny thing. a 40% reduction from trading range with all thats happened since the ann. (sure there has been dilution as well).
"The most important thing is to find out what is the most important thing." Shunryu Suzuki
(20min delay)